Leader of the scientific team and one of the founders of Micar Innovation Ltd. He has B.S. in Chemistry, M.S. in Physics and Ph.D. in Computational Chemistry and in silico bio-simulations and drug design.

Filip has more than 18 years’ experience in the above scientific fields and has worked for more than 8 years in highly qualified academic institutes and universities in E.U / USA:

  • Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy;
  • Technical University of Denmark, Center for Biological Sequence Analysis, Copenhagen, Denmark;
  • University of Bergen, Department of Molecular Biology, Bergen, Norway;
  • Bulgarian Academy of Sciences, Institute of Biophysics and Biomedical Engineering, Sofia, Bulgaria.
  • He has published more than 30 papers, as a first or solely author, and a book chapter that has received more than 250 citations. He is well recognized in this scientific field and was referee for the many prestige journals such as:

  • Journal of the American Chemical Society,
  • PLoS ONE,
  • The Journal of Physical Chemistry B,
  • Journal of Chemical Information and Modeling,
  • Chemical Reviews,
  • Current Medicinal Chemistry
  • and many others.

    He is a member of:
    The American Chemical Society (ACS)
    The American Society for Biochemistry and Molecular Biology (ASBMB)

    He is the leader of the divisions that perform molecular dynamics studies, protein modeling and docking screening.
    • efratev@micar21.com
    • h38A, Karamfil Street, 1616, Sofia, Bulgaria
    • wwww.micar21.com